Exosomes are one of the most potent intercellular communicators, which are able to communicate with adjacent or distant cells. Exosomes deliver various bioactive molecules, including membrane receptors, proteins, mRNA and microRNA, to target cells and serve roles. Recent studies have demonstrated that exosomes may regulate the functions and diseases of the skin, which is the largest organ of the human body. The abnormal functions of the skin lead to the progression of scleroderma, melanoma, baldness and other diseases. A previous study has demonstrated that epithelial progenitor cells are rich in several subunits of exosomes that may maintain the proliferative capacity of these epithelial progenitor cells, which is essential for the development of the epidermis. Exosomes derived from human adipose mesenchymal stem cells accelerate skin wound healing by optimizing fibroblast properties; this is beneficial for the recovery of postoperative and other wounds. Exosomes derived from adipocytes promote melanoma migration and invasion through fatty acid oxidation; therefore, in the clinic, it may be possible to improve the prognosis of patients with melanoma by reducing their body fat content. Exosomes derived from keratinocytes modulate melanocyte pigmentation, which has been utilized as a novel mechanism for the regulation of pigmentation in conditions including Moynahan syndrome and albinism. Meanwhile, scleroderma patients with vascular abnormalities may experience decreased serum exosome levels; it may therefore be possible to detect the exosome content in sera in order to diagnose and treat scleroderma. In addition, the use of exosomes has been suggested to promote or enhance hair growth, which has been demonstrated to be highly effective. These studies have provided new opportunities and therapeutic strategies for understanding how exosomes regulate intercellular communication in pathological processes of the skin.
exosomesskinfunctiondiseaseIntroduction
Skin refers to an organization of tissues on the surface of the body and is the largest organ of the human body, accounting for 16% of the body weight (1). Skin is the physical, chemical and immunological barrier of organisms. Thus, skin prevents the loss of useful substances from an organism. Skin also undertakes various functions, including repairing itself, perspiring, detecting temperature and pressure, and providing additional structural support (2–4). The development and function of the skin are affected by multiple factors, including environmental factors and hormones (5). Recently, exosome studies have indicated that some exosomes are involved in the physiological and pathological processes of the skin (6,7). Such findings have provided a novel perspective for the understanding of the molecular mechanisms involved in these processes.
Exosomes are small cell-derived vesicles (~100 nm in diameter) that are found in the majority of, if not all, biological fluids (8). Exosomes originate from endosomes and deliver various bioactive molecules to target cells (9). The recognition of exosomes by target cells is a specific, and involves the following events: i) Recognition between surface receptors; ii) direct fusion of the exosome with target cell membrane; and iii) ingestion by the target cell through endocytosis (10). They are important mediators of cell-to-cell communication, which is involved in multiple processes, including the immune response, apoptosis, angiogenesis and inflammation (11). Cells secrete exosomes that present signal molecules to nearby or distant tissues or cells, serving a regulatory role (12). To date, the mechanism of action of exosomes is poorly understood. Therefore, further studies are required to determine how exosomes regulate skin diseases and functions.
To date, studies on exosomes have become gradually applicable in clinical practice. For instance, exosome mRNA may be used as a diagnostic marker for lung cancer (13), exosome-derived glutathione peroxidase 1 may restore hepatic oxidant injury (14), and exosomal glypican 1 and its regulatory miRNAs may be specific markers for the detection and targeted therapy of colorectal cancer (15). With further study, the clinical applications of exosome markers may be increased.
Skin
The skin is a complex structure composed of multiple cell types and proteins, which comprise the epidermis, dermis and subcutaneous tissue (3). Skin is the indispensable barrier between the organism and the environment. Barrier function is an irreplaceable function of the skin (16), and the skin contains various accessory organs (17). There are multiple types of cells that secrete exosomes in the skin, for example keratinocytes, fibroblasts and adipocytes secrete exosomes into other cells or body fluids to participate in biological activity (6,18,19).
Skin diseases, including viral dermatosis, fungal dermatosis, connective tissue disease, pigmented dermatosis and skin tumors, are among the most common diseases in humans (20,21). Damage to the physiological function and normal structure of the skin may lead to skin diseases (22). Understanding the pathogenesis of various types of skin diseases may contribute to the establishment of effective therapeutics. Therefore, more research should focus on ways to prevent and treat skin diseases. Various studies have identified an association between exosomes and skin diseases (23–25). For instance, melanoma cells secrete exosomes, which are abundant in the tumor microenvironment, to impact on the pathological process (26).
Biological characteristics of exosomes
Exosomes are a kind of 40–100-nm biological membrane-bound structure, which are secreted by a variety of cells, including hematopoietic cells, mesenchymal stem cells (MSCs), adipocytes, keratinocytes and tumor cell lines, and released into the extracellular environment (27). Exosomes are widely distributed in body fluids (blood, urine and breast milk) (28). In 1983, Pan and Johnstone (29) first discovered exosomes in mammalian reticulocytes from mature sheep.
The origin of the exosomes is endocytosis (30). The inward budding of endosomes produces intraluminal vesicles (ILVs) that accumulate to form multivesicular bodies (MVBs). MVBs fuse with the plasma membrane, then release ILVs into the extracellular space or biological fluids (31,32). This process of exosome formation is depicted in Fig. 1. Exosomes may be internalized by target cells to participate in various physiological or pathological processes (33). Exosomes have multiple specific marker proteins, including membrane transport and fusion proteins (GTPases, annexins and flotillin), tetraspannins (34), heat shock proteins (Hsps; heat shock cognate 70 and Hsp90), proteins involved in MVB biogenesis (Alix and tumor susceptibility gene 101 protein), as well as lipid-related proteins and phospholipases (35).
Exosomes derived from different cells or tissues have varying functions. A previous study on exosomes demonstrated that they were associated with cellular functions and disease states (36). Research has investigated the relationship between exosomes and the immune response (37). For example, exosomes released by stem cells have been indicated to contribute to the treatment of autoimmune diseases (38). Alloreactive T cells may be activated by the exosomes secreted by donor dendritic cells (39). Furthermore, the roles of exosomes in cancer have been reported. Cancer-associated fibroblast-derived exosomes have been demonstrated to alter the metabolic mechanism of tumor cells (40). High-grade ovarian cancer cells secrete effective exosomes that serve an influential role in tumor angiogenesis (41). Tumor cell-derived exosomes are involved in tumor progression by multiple mechanisms, including proliferation, invasion, immunosuppression and formation of the premetastatic niche (42). For instance, tumor cell-derived exosomes are able to destroy the host immune system, and enhance tumor cell survival, growth and migration (43).
In addition, exosomes contain biologically active substances, including proteins, mRNA, microRNA (miRNA), cytokines and transcription factors (44). miRNA, single-chain and non-coding RNA with a length of 18–25 nt, regulate gene expression at the post-transcriptional level (45). miRNA interact with mRNA and have been indicated to degrade target mRNA or inhibit target mRNA translation (7). A single miRNA may regulate several target mRNA, and multiple miRNA may also bind to one target mRNA (46). Increasing evidence suggests that miRNA serve a critical role in multiple biological functions (47). Exosomes derived from MSCs attenuate renal fibrosis via miRNA let7c (48). Adipose tissue-derived MSC exosomes enhance hepatocellular carcinoma chemosensitivity by delivering miRNA-122 to the tumor cells (49). miRNA-9 and miRNA-124 of exosomes released into the serum may be utilized as biomarkers for acute ischemic stroke and to evaluate the degree of damage caused by ischemic injury (50). However, in the present review, the predominant focus will be on the regulation of skin functions and diseases by exosomes. These physiological and pathological processes in which exosomes are involved are outlined in Table I.
Exosomes and skin development
The development of the skin, particularly the epidermis, is essential for the survival of organisms. If the epidermis cannot be sufficiently self-renewed and differentiated, it may lead to a variety of skin diseases (51). Balance between this self-renewal and differentiation needs to be regulated by progenitor and stem cells (52). A previous study demonstrated that subunits of the exosomes (EXOSC7, EXOSC9 and EXOSC10) are abundant in epidermal progenitor cells, and are essential to avoid premature differentiation of progenitor cells (53), the mechanism for which may involve reduced production of grainyhead like transcription factor 3, a transcription factor essential for epidermal differentiation, through targeted degradation of its mRNA (53,54).
Wnt signaling pathways serve an important role in various developmental processes, such as the self-renewal of mammalian skin or tissue (55). A previous study identified that Wnt proteins are transported through the exosomes (56). Wnt induces the activation of β-catenin in endothelial cells by exosomes, thus promoting skin repair (57).
Hair of humans is the role of necessity and metabolism, and its predominant function is for warmth in mammals. Androgenetic alopecia is a common chronic skin condition that leads to hair loss in humans (58). A patented clinical study suggested that a pharmaceutical composition prepared by using exosomes may promote or enhance hair growth, making the hair thicker and longer. The exosomes were secreted by stem cells, such as MSCs (59).
Exosomes and skin pigmentation
The occurrence and mechanisms of skin and hair color development in mammals and humans are complicated and affected by multiple factors. Pigmentation is the core of the process, and is predominantly regulated by α-melanocyte-stimulating hormone/melanocortin 1 receptor, mitogen-activated protein kinase (stem cell factor/c-Kit), eosinophil-derived neurotoxin and the Wnt signaling pathway (60). Skin pigmentation requires close communication between cells. In the skin epidermis, melanocytes and keratinocytes form the epidermal melanin unit (6). Ultraviolet B is able to induce melanin production in melanoma cells (6). The difference in skin color is controlled by the melanin content (61). Abnormal skin pigmentation may lead to hyper and hypopigmentation disorder; a study by Lo Cicero et al (6) recently indicated that human keratinocyte-derived exosomes carry specific miRNA (miRNA-3196 and miRNA-203) and target melanocytes to regulate pigmentation, through the alteration of gene expression and the activation of key enzymes.
Vitiligo is a common pigmentation disorder of the skin, caused by the loss of functional melanocytes (62). The data presented in a previous study demonstrated that exosomes isolated from sera of active vitiligo patients differentially expressed 47 miRNA compared with healthy controls (23). This indicated a difference in the miRNAs between the serum exosomes of patients with vitiligo and those of healthy individuals, and contributed to understanding the role of melanocytes in the pathogenesis of vitiligo. Such research may allow for the development of a novel approach to manipulate pigmentation via exosomes, including crosstalk between melanocytes and keratinocytes, and the pathogenesis of abnormal pigment disorders.
Exosomes and skin wound healing
Previous studies, listed below, have indicated that exosomes promote skin wound healing through a paracrine mechanism, and suggest that the principal mechanism depends on the source of the exosomes. However, cells derived from different sources, including adipose mesenchymal cells and human amniotic epithelial cells, have demonstrated similar characteristics to MSCs (63). Exosomes of endothelial progenitor cells from human umbilical cord blood may also accelerate skin wound healing (64). Exosomes released from human induced pluripotent stem cell-derived MSCs have the ability of tissue repair by promoting collagen synthesis and angiogenesis (63). Similarly, exosomes secreted by cardiosphere-derived cells contribute to scar reduction (65).
In addition, adipose MSC-derived exosomes (ASCs-Exos) are internalized by fibroblasts to influence cell migration, proliferation and collagen synthesis (24). Histological analyses have indicated that the effect of ASCs-Exos on collagen is different between the early and later stages of wound healing, with increased collagen I and III synthesis at early stages and decreased collagen synthesis at later stages (24). ASCs-Exos may also promote cutaneous wound healing via optimizing the properties of fibroblasts (24). Human amniotic epithelial cell-derived exosomes have been demonstrated to expedite wound healing and inhibit scar formation by promoting proliferation and migration of fibroblasts (66). Human umbilical cord MSC-derived exosomes (hucMSC-Exos) through the Wnt4 pathway are also involved in skin wound healing. HucMSC-Exos facilitate the function of endothelial cells; various studies have demonstrated that the hucMSC-Exo-mediated Wnt4 pathway induced β-catenin activation in endothelial cells and enhanced vascular regeneration (57,67). Furthermore, research has suggested that exosomes from the serum may accelerate wound healing in mice, predominantly due to the impact on collagen synthesis (68).
At present, the most notably obstacle in the treatment of skin wounds is how to prolong healing, particularly in the cases of wound recovery in diabetic patients and patients who have received surgery. Therefore, exosomes may provide a promising approach for skin wound repair.
Exosomes and skin cancer
Skin cancer is a common disease and the morbidity is increasing dramatically, particularly in Caucasians. For example, the incidence of skin cancer among Caucasians in America reached 165 per 10,000 individuals in 2015 (69,70). Skin cancers include melanoma, basal cell carcinoma and squamous cell carcinoma (SCC); the latter two diseases are non-melanoma (69). Tumor cell-derived exosomes are abundant in the tumor microenvironment; they contribute to the formation of the premetastatic niche and attack the host's immune system (26). Exosomes may be used as an effective tool in cancer diagnosis and prognosis due to their particular pro-tumorigenic characteristics (25).
Melanoma, also known as malignant melanoma, forms through malignant transformation of melanocytes and often occurs in the skin. Melanoma is the most malignant tumor of the skin tumors (71). Due to the aggressiveness, ease of distant metastasis and treatment resistance, melanoma has a high mortality rate (72–74). Early diagnosis and treatment is therefore particularly important.
A study by Hood et al (75) demonstrated that melanoma exosomes induced different patterns in the sentinel lymph node genes, which was dependent on the establishment of the angiogenesis mode of the matrix structure. This was conducive to the growth of the tumor. In melanoma cells, Wnt5A strengthens the capacity of invasion and metastasis by inducing the immunomodulatory and pro-angiogenic factors released from exosomes (76). Melanoma exosomes may promote the ability of lymph node tumor tolerance mediated by myeloid-derived suppressor cells and lymphatic endothelial cells, which leads to damage to the function of tumor immune surveillance in lymph nodes (77).
Previous studies have indicated that miRNA are also closely related to melanoma (7,78–80). For instance, melanoma cells secrete exosomes carrying miR-222 to promote tumorigenesis by activating the phosphoinositide 3-kinase/AKT pathway (7). The expression level of miRNA-125b was downregulated in serum exosomes of patients with melanoma compared with the levels in healthy individuals. miRNA-125b is a characteristic miRNA from melanoma-derived exosomes, which may directly inhibit the expression of c-Jun protein and control the development of melanoma (81). miRNA-17, −19a, −21, −126 and −149 were highly expressed in the exosomes of patients with metastatic sporadic melanoma compared with the levels in patients with familial melanoma and normal controls. Notably, there was no significant difference in the miRNA expression level between the healthy controls and the patients with familial melanoma (82).
Non-melanoma, predominantly SCC, may use exosomes to increase crosstalk between tumor cells and the tumor microenvironment (83). Transforming growth factor-β (TGF-β) signaling is important for cancer occurrence and development. It has been demonstrated that exosomes in the tumor microenvironment have the ability to re-activate TGF-β signaling in SSC (84). Exosomes secreted from head and neck SCC cells change their protein composition in response to ionizing radiation, which may induce changes in translation or transcription (85). Relevant research data has indicated that the exosomes of head and neck SCC cells also promote the survival of recipient cells (83).
In summary, exosomes serve an important role in the occurrence and development of tumors. Full elucidation of the mechanism of exosome function is conducive to the diagnosis and treatment of skin cancer.
Exosomes and other skin diseases
Scleroderma is a connective tissue disease, and its main features include endothelial cell dysfunction, immune activation and excessive skin fibrosis (86). A previous study demonstrated that patients with scleroderma had a reduced level of exosomes in their serum, which was predominantly due to vascular abnormalities disrupting the transportation of exosomes derived from the fibrocytes of skin tissue (68,87). However, in dermatomyositis and scleroderma overlap syndrome, exosomes exist as an autoantigenic complex (88,89).
Another disease associated with skin is obesity. Obesity is a common metabolic syndrome and a systemic inflammatory state that affects almost every organ system in the body (90). Adipocytes of people with obesity may induce inflammation (91). Fortunately, adipocyte-derived exosomes may carry miRNA to regulate end-organ TGF-β and Wnt/β-catenin signaling, which are inflammatory and fibrotic signaling pathways (92). A recent study supports this view; the exosome-like vesicles secreted by adipose tissues carry ~one third of miRNA relevant to adipogenesis to induce adipogenesis of adipose tissue-derived stem cells (93). A study by Skowron et al (94) suggested that obesity increased the risk of melanoma malignant metastasis. Recently, a mechanism by which exosomes are linked to obesity and melanoma was identified. It was revealed that adipocyte exosomes carried the majority of proteins involved in lipid metabolism, primarily for fatty acid oxidation. Crucially, this feature contributed to the migration and invasion of melanoma cells (19,95). These results may explain why patients with obesity and melanoma have a poor prognosis, and may lead to a novel strategy for the treatment of melanoma by reducing body fat content or inhibiting fatty acid oxidation.
Conclusion
The discovery and confirmation of the role of exosomes has had a profound influence on the understanding of organism physiology and pathological processes. Exosomes not only carry pathological or physiological marker proteins/RNA of donor cells, but may also act as a vehicle for the transfer of drugs and other molecules to lesion sites. Furthermore, exosomes also have the potential to be modified and processed. In the present review, exosomes involved in skin development, function and diseases were discussed. Further in-depth studies of exosomes are required to determine whether they may be utilized as high-performance tools and as a novel pathway for regulating skin development and diseases in the future.
Acknowledgements
Not applicable.
Funding
The present study was supported by grants from the National Natural Science Foundation of China (grant nos. 81700650 and 31772690).
Availability of data and materials
Not applicable.
Authors' contributions
YL drafted the article, HW revised the article and JW provided ideas and helped to improve language accuracy.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
ReferencesNgKWLauWMSpringer-VerlagBerlin Heidelberg, New York2015MenonGKSkin basics; structure and functionSpringer International PublishingSwitzerland9232015BarbieriJSWanatKSeykoraJSkin: Basic structure and functionAcademic Press11341144201410.1016/B978-0-12-386456-7.03501-2McgrathJAEadyRAJPopeFMAnatomy and organization of human skin7thWiley451282008HayRJJohnsNEWilliamsHCBolligerIWDellavalleRPMargolisDJMarksRNaldiLWeinstockMAWulfSKThe global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions13415271534201410.1038/jid.2013.44624166134Lo CiceroADelevoyeCGilles-MarsensFLoewDDingliFGuéréCAndréNViéKvan NielGRaposoGExosomes released by keratinocytes modulate melanocyte pigmentation67506201510.1038/ncomms850626103923FelicettiFDe FeoACosciaCPuglisiRPediniFPasquiniLBellenghiMErricoMCPaganiECarèAExosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma1456201610.1186/s12967-016-0811-226912358LinJLiJHuangBLiuJChenXChenXMXuYMHuangLFWangXZExosomes: Novel biomarkers for clinical diagnosis2015657086201510.1155/2015/657086ProperziFLogozziMFaisSExosomes: The future of biomarkers in medicine7769778201310.2217/bmm.13.63CocucciERacchettiGMeldolesiJShedding microvesicles: Artefacts no more194351200910.1016/j.tcb.2008.11.00319144520BachDHHongJYParkHJLeeSKThe role of exosomes and miRNAs in drug-resistance of cancer cells141220230201710.1002/ijc.3066928240776LaiRCChenTSLimSKMesenchymal stem cell exosome: A novel stem cell-based therapy for cardiovascular disease6481492201110.2217/rme.11.3521749206RabinowitsGGerçel-TaylorCDayJMTaylorDDKloeckerGHExosomal microRNA: A diagnostic marker for lung cancer104246200910.3816/CLC.2009.n.00619289371YanYJiangWTanYZouSZhangHMaoFGongAQianHXuWhucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury25465479201710.1016/j.ymthe.2016.11.01928089078LiJChenYGuoXZhouLJiaZPengZTangYLiuWZhuBWangLRenCGPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer21838847201710.1111/jcmm.1294128233416ProkschEBrandnerJMJensenJMThe skin: An indispensable barrier1710631072200810.1111/j.1600-0625.2008.00786.x19043850ForslindBLindbergMCRC Press2003BangCBatkaiSDangwalSGuptaSKFoinquinosAHolzmannAJustARemkeJZimmerKZeugACardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy12421362146201410.1172/JCI7057724743145HolmesDAdipose tissue: Adipocyte exosomes drive melanoma progression12436201610.1038/nrendo.2016.94BickersDRAtharMOxidative stress in the pathogenesis of skin disease12625652575200610.1038/sj.jid.570034017108903AkitaNSawamuraDMatsumuraKNomuraKClinical study of diflorasone diacetate ointment (Diflal® ointment) in various types of skin diseases291151192010BalatoNMegnaMAyalaFBalatoANapolitanoMPatrunoCEffects of climate changes on skin diseases12171181201410.1586/14787210.2014.87585524404995LiuLSongPYiXLiCGaoT067 Serum-derived exosomes contribute to abnormal melanocyte function in patients with active vitiligo136S12S12201610.1016/j.jid.2016.02.092HuLWangJZhouXXiongZZhaoJYuRHuangFZhangHChenLExosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts632993201610.1038/srep3299327615560GoedertLKoyaRHu-LieskovanSRibasAExosomes as a predictor tool of acquired resistance to melanoma treatment8Suppl 4P28201410.1186/1753-6561-8-S4-P28XiaoDBarrySKmetzDEggerMPanJRaiSNQuJMcMastersKMHaoHMelanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment376318327201610.1016/j.canlet.2016.03.05027063098SimpsonRJJensenSSLimJWProteomic profiling of exosomes: Current perspectives840834099200810.1002/pmic.20080010918780348VlassovAVMagdalenoSSetterquistRConradRExosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials1820940948201210.1016/j.bbagen.2012.03.01722503788PanBTJohnstoneRMFate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor33967978198310.1016/0092-8674(83)90040-56307529MathivananSJiHSimpsonRJExosomes: Extracellular organelles important in intercellular communication7319071920201010.1016/j.jprot.2010.06.00620601276SimpsonRJLimJWMoritzRLMathivananSExosomes: Proteomic insights and diagnostic potential6267283200910.1586/epr.09.1719489699LakkarajuARodriguez-BoulanEItinerant exosomes: Emerging roles in cell and tissue polarity18199209200810.1016/j.tcb.2008.03.00218396047van NielGPorto-CarreiroISimoesSRaposoGExosomes: A common pathway for a specialized function1401321200610.1093/jb/mvj12816877764SeguraMFHannifordDMenendezSReavieLZouXAlvarez-DiazSZakrzewskiJBlochinERoseABogunovicDAberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor10618141819200910.1073/pnas.080826310619188590Conde-VancellsJRodriguez-SuarezEEmbadeNGilDMatthiesenRValleMElortzaFLuSCMatoJMFalcon-PerezJMCharacterization and comprehensive proteome profiling of exosomes secreted by hepatocytes751575166200810.1021/pr800488719367702ZhouHCheruvankyAHuXMatsumotoTHiramatsuNChoMEBergerALeelahavanichkulADoiKChawlaLSUrinary exosomal transcription factors, a new class of biomarkers for renal disease74613621200810.1038/ki.2008.20618509321ThéryCOstrowskiMSeguraEMembrane vesicles as conveyors of immune responses9581593200910.1038/nri256719498381IchimTBoginVUS Patent 20160361399 A1August42016issued December 15, 2016LiuQRojas-CanalesDMDivitoSJShufeskyWJStolzDBErdosGSullivanMLGibsonGAWatkinsSCLarreginaATDonor dendritic cell-derived exosomes promote allograft-targeting immune response12628052820201610.1172/JCI8457727348586ZhaoHYangLBaddourJAchrejaABernardVMossTMariniJCTudaweTSeviourEGSan LucasFATumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism5e10250201610.7554/eLife.1025026920219YiHYeJYangXMZhangLWZhangZGChenYPHigh-grade ovarian cancer secreting effective exosomes in tumor angiogenesis850625070201526191200TicknerJAUrquhartAJStephensonSARichardDJO'ByrneKJFunctions and therapeutic roles of exosomes in cancer4127201410.3389/fonc.2014.0012724904836SaleemSNAbdel-MageedABTumor-derived exosomes in oncogenic reprogramming and cancer progression72110201510.1007/s00018-014-1710-425156068ChevilletJRKangQRufIKBriggsHAVojtechLNHughesSMChengHHArroyoJDMeredithEKGallichotteENQuantitative and stoichiometric analysis of the microRNA content of exosomes1111488814893201410.1073/pnas.140830111125267620BiSWangCJinYLvZXingXLuQCorrelation between serum exosome derived miR-208a and acute coronary syndrome842754280201526064341WangHWangBExtracellular vesicle microRNAs mediate skeletal muscle myogenesis and disease5296300201610.3892/br.2016.72527588172HumphriesBPhD dissertationMichigan State University2016WangBYaoKHuuskesBMShenHHZhuangJGodsonCBrennanEPWilkinson-BerkaJLWiseAFRicardoSDMesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis2412901301201610.1038/mt.2016.9027203438LouGSongXYangFWuSWangJChenZLiuYExosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma8122201510.1186/s13045-015-0220-726514126JiQJiYPengJZhouXChenXZhaoHXuTChenLXuYIncreased brain-specific miR-9 and miR-124 in the serum exosomes of acute ischemic stroke patients11e0163645201610.1371/journal.pone.016364527661079JacksonSJZhangZFengDFlaggMO'LoughlinEWangDStokesNFuchsEYiRRapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation14018821891201310.1242/dev.08964923571213NijhofJGvan PeltCMulderAAMitchellDLMullendersLHde GruijlFREpidermal stem and progenitor cells in murine epidermis accumulate UV damage despite NER proficiency28792800200710.1093/carcin/bgl21317127714MistryDSChenYSenGLProgenitor function in self-renewing human epidermis is maintained by the exosome11127135201210.1016/j.stem.2012.04.02222770246NoiretMMottierSAngrandGGautier-CourteilleCLerivrayHVietJPaillardLMereauAHardySAudicYPtbp1 and Exosc9 knockdowns trigger skin stability defects through different pathways409489501201610.1016/j.ydbio.2015.11.00226546114CleversHWnt/β-catenin signaling in development and disease127469480200610.1016/j.cell.2006.10.01817081971GrossJCChaudharyVBartschererKBoutrosMActive Wnt proteins are secreted on exosomes1410361045201210.1038/ncb257422983114ZhangBWangMGongAZhangXWuXZhuYShiHWuLZhuWQianHXuWHucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing3321582168201510.1002/stem.177124964196VarothaiSBergfeldWFAndrogenetic alopecia: An evidence-based treatment update15217230201410.1007/s40257-014-0077-524848508LimSKYeoMSWChenTSLaiRCEP Patent 2629782 A1October172011issued August 28, 2013LinJYFisherDEMelanocyte biology and skin pigmentation445843850200710.1038/nature0566017314970RawlingsAVEthnic skin types: Are there differences in skin structure and function?287993200610.1111/j.1467-2494.2006.00302.x18492142WhittonMPinartMBatchelorJMLeonardi-BeeJGonzalezUJiyadZEleftheriadouVEzzedineKEvidence-based management of vitiligo: Summary of a Cochrane systematic review174962969201610.1111/bjd.1435626686510ZhangJGuanJNiuXHuGGuoSLiQXieZZhangCWangYExosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis1349201510.1186/s12967-015-0417-025638205LiXJiangCZhaoJHuman endothelial progenitor cells-derived exosomes accelerate cutaneous wound healing in diabetic rats by promoting endothelial function30986992201610.1016/j.jdiacomp.2016.05.00927236748GalletRDawkinsJValleJSimsoloEde CoutoGMiddletonRTseliouELuthringerDKrekeMSmithRRExosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction38201211201728158410ZhaoBZhangYHanSZhangWZhouQGuanHLiuJShiJSuLHuDExosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation48121132201710.1007/s10735-017-9711-x28229263ZhangBWuXZhangXSunYYanYShiHZhuYWuLPanZZhuWHuman umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway4513522201510.5966/sctm.2014-026725824139NakamuraKJinninMFukushimaSIhnHExosome expression in the skin and sera of systemic sclerosis patients, and its possible therapeutic application against skin ulcer84e97e98201610.1016/j.jdermsci.2016.08.295DiepgenTLMahlerVThe epidemiology of skin cancer146Suppl 6116200210.1046/j.1365-2133.146.s61.2.x11966724WernliKJHenriksonNBMorrisonCCNguyenMPocobelliGBlasiPRScreening for skin cancer in adults: Updated evidence report and systematic review for the US Preventive Services Task Force316436447201610.1001/jama.2016.541527458949HodiFSO'DaySJMcDermottDFWeberRWSosmanJAHaanenJBGonzalezRRobertCSchadendorfDHasselJCImproved survival with ipilimumab in patients with metastatic melanoma363711723201010.1056/NEJMoa100346620525992AlegreEZubiriLPerez-GraciaJLGonzález-CaoMSoriaLMartín-AlgarraSGonzálezACirculating melanoma exosomes as diagnostic and prognosis biomarkers4542832201610.1016/j.cca.2015.12.03126724367Gray-SchopferVWellbrockCMaraisRMelanoma biology and new targeted therapy445851857200710.1038/nature0566117314971Gajos-MichniewiczADuechlerMCzyzMmiRNA in melanoma-derived exosomes3472937201410.1016/j.canlet.2014.02.00424513178HoodJLSanRSWicklineSAExosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis7137923801201110.1158/0008-5472.CAN-10-445521478294EkströmEJBergenfelzCvon BülowVSeriflerFCarlemalmEJönssonGAnderssonTLeanderssonKWNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells1388201410.1186/1476-4598-13-8824766647HoodJLMelanoma exosomes enable tumor tolerance in lymph nodes901113201610.1016/j.mehy.2016.02.01827063077ShoshanEMobleyAKBraeuerRRKamiyaTHuangLVasquezMESalamehALeeHJKimSJIvanCReduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis17311321201510.1038/ncb311025686251ZhouJXuDXieHTangJLiuRLiJWangSChenXSuJZhouXmiR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α16846855201510.1080/15384047.2015.103054525891797BhattacharyaASchmitzURaatzYSchönherrMKottekTSchauerMFranzSSaalbachAAndereggUWolkenhauerOmiR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy629662980201510.18632/oncotarget.307025650662AlegreESanmamedMFRodriguezCCarranzaOMartín-AlgarraSGonzálezAStudy of circulating microRNA-125b levels in serum exosomes in advanced melanoma138828832201410.5858/arpa.2013-0134-OA24878024PfefferSRGrossmannKFCassidyPBYangCHFanMKopelovichLLeachmanSAPfefferLMDetection of exosomal miRNAs in the plasma of melanoma patients420122027201510.3390/jcm412195726694476MutschelknausLPetersCWinklerKYentrapalliRHeiderTAtkinsonMJMoertlSExosomes derived from squamous head and neck cancer promote cell survival after ionizing radiation11e0152213201610.1371/journal.pone.015221327006994LanguinoLRSinghAPriscoMInmanGJLuginbuhlACurryJMSouthAPExosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma824322437201627347352JelonekKWojakowskaAMarczakLMuerATinhofer-KeilholzILysek-GladysinskaMWidlakPPietrowskaMIonizing radiation affects protein composition of exosomes secreted in vitro from head and neck squamous cell carcinoma62265272201510.18388/abp.2015_97026098714TokiSMotegiSYamadaKUchiyamaAKanaiSYamanakaMIshikawaOClinical and laboratory features of systemic sclerosis complicated with localized scleroderma42283287201510.1111/1346-8138.1277525582037NakamuraKJinninMHaradaMKudoHNakayamaWInoueKOgataAKajiharaIFukushimaSIhnHAltered expression of CD63 and exosomes in scleroderma dermal fibroblasts843039201610.1016/j.jdermsci.2016.06.01327443953BrouwerRPruijnGJvan VenrooijWJThe human exosome: An autoantigenic complex of exoribonucleases in myositis and scleroderma3102106200110.1186/ar14711178117Gutiérrez-RamosRGonz Lez-DíazVPacheco-TovarMGLópez-LunaAAvalos-DíazEHerrera-EsparzaRA dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies60296300200819132155BarkaiLParaghGMetabolic syndrome in childhood and adolescence1472432502006(In Hungarian)16610614RajalaMWSchererPEMinireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis14437653773200310.1210/en.2003-058012933646FerranteSCNadlerEPPillaiDKHubalMJWangZWangJMGordish-DressmanHKoeckESevillaSWilesAAFreishtatRJAdipocyte-derived exosomal miRNAs: A novel mechanism for obesity-related disease77447454201510.1038/pr.2014.20225518011ZhangYYuMDaiMChenCTangQJingWWangHTianWmiR-450a-5p within rat adipose tissue exosome-like vesicles promotes adipogenic differentiation by targeting WISP213011581168201728167681SkowronFBérardFBalmeBMaucort-BoulchDRole of obesity on the thickness of primary cutaneous melanoma29262269201510.1111/jdv.1251524750303LazarIClementEDauvillierSMilhasDDucoux-PetitMLeGonidecSMoroCSoldanVDalleSBalorSAdipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer7640514057201610.1158/0008-5472.CAN-16-065127216185
Process of exosome formation. ILVs, intraluminal vesicles; MVBs, multivesicular bodies.
Functions of exosomes in skin physiological and pathological processes.
Author, year
Process
Function
Source of exosomes
Mechanism of action
(Refs.)
Mistry et al, 2012
Skin development
Epidermal growth
Epidermal progenitor cells
Decrease expression of grainyhead like transcription factor 3
(53)
Lim et al, 2013
Skin development
Hair growth
Stem cells
Prepare pharmaceutical composition
(59)
Lo Cicero et al, 2015
Skin pigmentation
Pigmentation of melanocyte
Keratinocyte
Carry miRNA target to melanocytes
(6)
Liu et al, 2016
Skin pigmentation
Vitiligo pathogenesis
Serum of patients
miRNA carried by exosomes induce differential expression
(23)
Li et al, 2016
Skin wound healing
Skin wound healing
Human endothelial progenitor cells
Enhance proliferation, migration, tube formation and angiogenesis
(64)
Zhang et al, 2015
Skin wound healing
Skin wound healing
Human induced pluripotent stem cell-derived MSCs
Enhance proliferation, migration, tube formation and angiogenesis
(63)
Hu et al, 2016
Skin wound healing
Skin wound healing
Adipose MSCs
To obtain excellent fibroblasts
(24)
Zhao et al, 2017
Skin wound healing
Skin wound healing
Human amniotic epithelial cells
Promote proliferation and migration of fibroblasts
(66)
Zhang et al, 2015
Skin wound healing
Skin wound healing
Human umbilical cord MSCs
Activation of β-catenin via the Wnt4 pathway
(67)
Nakamura et al, 2016
Skin wound healing
Skin wound healing
Serum
Impact on collagen synthesis
(68)
Hood et al, 2011
Skin cancer
Melanoma pathogenesis
Melanoma cells
Encourage angiogenesis to promote growth of the tumor
(75)
Ekström et al, 2014
Skin cancer
Melanoma pathogenesis
Melanoma cells
Mediated by Wnt signaling to enhance tumor invasion and migration
(76)
Hood, 2016
Skin cancer
Melanoma pathogenesis
Melanoma cells
Damage tumor immune surveillance function in lymph nodes
(77)
Felicetti et al, 2016
Skin cancer
Melanoma pathogenesis
Melanoma cells
miRNA-222 activates the phosphoinositide 3-kinase/AKT pathway to promote tumorigenesis
(7)
Alegre et al, 2014
Skin cancer
Melanoma pathogenesis
Melanoma cells
miRNA-125b regulates the expression of c-Jun protein